Opteev to Debut Multiplex Biosensor that Detects and Identifies Numerous Virus and Bacteria Pathogens Including COVID, Flu, RSV, and Strep, in Under 60 Seconds
Sep 18, 2023
Opteev debuts game-changing biosensor at BIOMEDevice Boston. Detects & differentiates extensive array of pathogens in a single test in 60 seconds with over 99% accuracy.
(PRUnderground) September 18th, 2023
Opteev Technologies, Inc., a Baltimore-based pioneering technology company at the forefront of diagnostics, will be debuting its groundbreaking multiplex biosensor at the BIOMEDevice medical device expo in Boston on Wednesday, September 20th. Opteev’s impedance-based biosensor is capable of detecting and differentiating an extensive array of virus and bacteria pathogens in a single test in an astonishing 60 seconds with over 99% accuracy.
The company’s novel device offers a complete paradigm shift in healthcare, environmental monitoring, food safety, and at-home testing. In healthcare, the lightning-fast biosensor paves the way for the first comprehensive syndromic multiplex testing available at the Point of Care, enabling doctors to remove diagnostic guesswork so they can provide targeted treatment in real time. Furthermore, the technology grants air purifiers and HVAC systems the advanced functionality of identifying harmful pathogens to trigger immediate purification, affords rapid identification of foodborne pathogens from supply chains to home kitchens, and provides comprehensive diagnostics for at-home testing. Moreover, its adaptability to detect novel viruses upon receiving genetic sequencing data presents public health agencies the ultimate tool for surveillance and containment of future outbreaks.
“Imagine a world where over 70% of medical decisions aren’t mere educated guesses. That’s the change our biosensor brings to healthcare,” emphasized Dr. Mesfin Meshesha. “No longer will comprehensive diagnostics be a waiting game or a matter of affordability. And its impact resonates far beyond the walls of a clinic. Whether it’s ensuring the air we breathe is safe or providing society a fortified way of defending against future pandemics, our innovation ushers in a new era that will set the benchmark for decades to come.”
Conrad Bessemer, Opteev’s Chairman and Co-founder, further emphasized the disruptive potential of the technology: “BIOMEDevice Boston serves as a platform for us to not only introduce our novel biosensor but also to invite potential collaborators to join us. Together, we’re poised to reshape diagnostics and maximize the unprecedented potential of our technology.”
For a closer look at this revolutionary device, Opteev will be exhibiting its Multiplex Biosensor at the BIOMEDevice Boston event at the Boston Convention and Exhibition Center on Wednesday, September 20th and Thursday, September 21st at Booth #945.
As the company continues to advance diagnostic innovation, Opteev welcomes discussions on collaborations and partnerships, emphasizing a shared vision for the future of pathogen detection and infection diagnostics.
For more details on Opteev’s Multiplex Biosensor and the myriad opportunities it presents, please visit www.opteev.com.
About Opteev Technologies, Inc.
Opteev Technologies, Inc., headquartered in Baltimore, MD, is an innovative technology company at the forefront of diagnostics. A subsidiary of Novatec, Inc., Opteev combines deep expertise and an unwavering commitment to push the boundaries of rapid pathogen detection and diagnostics.
The post Opteev to Debut Multiplex Biosensor that Detects and Identifies Numerous Virus and Bacteria Pathogens Including COVID, Flu, RSV, and Strep, in Under 60 Seconds first appeared on
Press Contact
Name: Dana Gardner Phone: 4434575214 Email: Contact UsOriginal Press Release.
More News
California’s Potential Quartz Ban Pushes Contractors and Retailers to Alternatives
Manufacturers and their customers are using materials made without the clouds of dust that have sickened workers in quartz-cutting shops.
My Co-Worker Is Losing It Over My Religion
Plus: Reader responses to a woman returning to the office after two decades of self-employment.
My Co-Worker Is Losing It Over My Religion
Plus: Reader responses to a woman returning to the office after two decades of self-employment.
Who Stands to Gain From an Anthropic I.P.O.
Wall Street banks and chipmakers are among those poised to capitalize on the artificial intelligence giant’s public trading debut.
First-time buyer wary of Budget housing loan scheme
Luke Anstee has been saving for three years but says rising living costs make home ownership harder.
Holiday Travel Costs Are Soaring. Here’s How to Save.
As airfares and gas prices surge, here’s how you can extend your travel budget.
U.S. Pensions Are Riding the A.I. Wave. For Better or Worse.
As exuberance around the technology stokes fears of a bubble, the nation’s public pensions are starting to grapple with their role — and their risks.
In Anthropic I.P.O., Goldman and Morgan Stanley Slug It Out for Top Bank
Anthropic named the Wall Street firms lead underwriters on its upcoming public offering, a role that will generate generous fees and enormous prestige.
Apple to replace iPhone Duos affected by screen problem
Photos shared online showed faults appearing on the screens of Apple's first foldable device.
In Anthropic I.P.O., Goldman and Morgan Stanley Slug It Out for Top Bank
Anthropic named the Wall Street firms lead underwriters on its upcoming public offering, a role that will generate generous fees and enormous prestige.
The Fed Is Expected to Hold Rates Steady. Warsh Will Have to Explain Why.
Inflation is moving in the wrong direction and the labor market remains stable, a combination that bolsters the case for higher interest rates.
The Fed Is Expected to Hold Rates Steady. Warsh Will Have to Explain Why.
Inflation is moving in the wrong direction and the labor market remains stable, a combination that bolsters the case for higher interest rates.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.